Hims & Hers Shares Drop Following Amazon's Expansion into Telehealth
Hims & Hers Health ( HIMS, Financials) shares slumped 24.5% on Thursday as Amazon ( AMZN, Financials) expanded into hair loss and erectile dysfunction treatment sectors; shares are recovering somewhat ...
Dupixent® (Dupilumab) Sbla Accepted For FDA Review For The Treatment Of Chronic Spontaneous Urticaria (CSU)
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...